Literature DB >> 9481623

Upstream sequencing and functional characterization of the human cholinergic gene locus.

S H Hahm1, L Chen, C Patel, J Erickson, T I Bonner, E Weihe, M K Schäfer, L E Eiden.   

Abstract

The 5' flanking region of the human VAChT gene was sequenced to approx 5350 bases upstream of the initiating methionine codon of the VAChT open reading frame (orf). The 5' flanks of the human and rat cholinergic gene loci were compared to identify regions of local sequence conservation, and therefore of potential regulatory importance. Several discrete domains of high homology, including a cluster of far-upstream cis-active consensus motifs, a neuronally restrictive silencer element consensus sequence, and additional conserved sequences within the putative nerve growth factor response domain of the locus, were identified. The probable start of transcription of the VAChT gene was deduced from mapping of sequences of rat and human VAChT cDNAs onto the 5' flanking regions of the human and rat cholinergic gene loci. The actual utilization of a putative 5' VAChT exon in rat central nervous system (CNS) tissue was assessed by in situ hybridization histochemistry. RNA transcripts containing both VAChT and ChAT protein-coding sequences were abundant in spinal cord motoneurons, sympathetic preganglionic cells, basal forebrain, striatum, and cranial motor nuclei. R-exon-containing transcripts could be detected only at low levels in these cell groups, implying that most transcription of VAChT proceeds from a promoter downstream of the R-exon. To assess the structural requirements for expression of the VAChT gene without bias regarding the actual start of transcription, a 5' fragment of the human gene corresponding to approximately 3 kb of sequence extending upstream from within the presumed 5' untranslated region of VAChT itself was fused to a luciferase-encoding reporter and transfected into VAChT-expressing and nonexpressing human and rat cell lines. This portion of the VAChT gene provided strong promoter expression in both cholinergic and noncholinergic cell lines. Deletion of the putative neuronally restrictive silencer element (NRSE) resulted in enhanced transcription in all cell lines. Lack of differential expression of VAChT transcription in VAChT-expressing vs non-VAChT-expressing cell lines suggested that additional enhancer elements controlling cell-specific expression of the VAChT gene exist further upstream in the cholinergic locus 5' flank. Conservation of potential cis-active elements within a 1.4 kb sequence immediately upstream of the NRSE in both rat and human cholinergic gene loci suggests that this domain is required for cholinergic-specific regulation of VAChT and ChAT gene transcription.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9481623     DOI: 10.1007/BF02800504

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  31 in total

1.  Complete sequence of a cDNA encoding an active rat choline acetyltransferase: a tool to investigate the plasticity of cholinergic phenotype expression.

Authors:  A Brice; S Berrard; B Raynaud; S Ansieau; T Coppola; M J Weber; J Mallet
Journal:  J Neurosci Res       Date:  1989-07       Impact factor: 4.164

Review 2.  Molecular biology of the vesicular ACh transporter.

Authors:  T B Usdin; L E Eiden; T I Bonner; J D Erickson
Journal:  Trends Neurosci       Date:  1995-05       Impact factor: 13.837

3.  Integration of Jak-Stat and AP-1 signaling pathways at the vasoactive intestinal peptide cytokine response element regulates ciliary neurotrophic factor-dependent transcription.

Authors:  A Symes; T Gearan; J Eby; J S Fink
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

4.  Histone hyperacetylating agents stimulate promoter activity of human choline acetyltransferase gene in transfection experiment.

Authors:  M Chireux; E Espinos; S Bloch; M Yoshida; M J Weber
Journal:  Brain Res Mol Brain Res       Date:  1996-07

5.  Human choline acetyltransferase mRNAs with different 5'-region produce a 69-kDa major translation product.

Authors:  H Misawa; J Matsuura; Y Oda; R Takahashi; T Deguchi
Journal:  Brain Res Mol Brain Res       Date:  1997-03

6.  The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes.

Authors:  C J Schoenherr; D J Anderson
Journal:  Science       Date:  1995-03-03       Impact factor: 47.728

7.  Promoter elements of the rat choline acetyltransferase gene allowing nerve growth factor inducibility in transfected primary cultured cells.

Authors:  S Bejanin; E Habert; S Berrard; J B Edwards; J P Loeffler; J Mallet
Journal:  J Neurochem       Date:  1992-04       Impact factor: 5.372

8.  Localization of Sequences Determining Cell Type Specificity and NGF Responsiveness in the Promoter Region of the Rat Choline Acetyltransferase Gene.

Authors:  Carlos F. Ibáñez; Håkan Persson
Journal:  Eur J Neurosci       Date:  1991       Impact factor: 3.386

9.  Ciliary neurotrophic factor coordinately activates transcription of neuropeptide genes in a neuroblastoma cell line.

Authors:  A J Symes; M S Rao; S E Lewis; S C Landis; S E Hyman; J S Fink
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

10.  Identification of potential target genes for the neuron-restrictive silencer factor.

Authors:  C J Schoenherr; A J Paquette; D J Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  8 in total

1.  Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease.

Authors:  Denise Harold; Timothy Peirce; Valentina Moskvina; Amanda Myers; Susan Jones; Paul Hollingworth; Pamela Moore; Simon Lovestone; John Powell; Catherine Foy; Nicola Archer; Sarah Walter; Amanda Edmonson; Stephen McIlroy; David Craig; Peter A Passmore; Alison Goate; John Hardy; Michael O'Donovan; Julie Williams; Malcolm Liddell; Michael J Owen; Lesley Jones
Journal:  Hum Genet       Date:  2003-05-21       Impact factor: 4.132

2.  The sympathetic neurotransmitter switch depends on the nuclear matrix protein Satb2.

Authors:  Galina Apostolova; Bernhard Loy; Roland Dorn; Georg Dechant
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

3.  The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes.

Authors:  K Kuwahara; Y Saito; E Ogawa; N Takahashi; Y Nakagawa; Y Naruse; M Harada; I Hamanaka; T Izumi; Y Miyamoto; I Kishimoto; R Kawakami; M Nakanishi; N Mori; K Nakao
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 4.  The cholinergic neuronal phenotype in Alzheimer's disease.

Authors:  J K Blusztajn; B Berse
Journal:  Metab Brain Dis       Date:  2000-03       Impact factor: 3.584

5.  Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans.

Authors:  K Ohno; A Tsujino; J M Brengman; C M Harper; Z Bajzer; B Udd; R Beyring; S Robb; F J Kirkham; A G Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

6.  Abnormal chemosensory jump 6 is a positive transcriptional regulator of the cholinergic gene locus in Drosophila olfactory neurons.

Authors:  Mi-Heon Lee; Paul M Salvaterra
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

Review 7.  Association of Choline Acetyltransferase Gene Polymorphisms (SNPs rs868750G/A, rs1880676G/A, rs2177369G/A and rs3810950G/A) with Alzheimer's Disease Risk: A Meta-Analysis.

Authors:  Hai Yuan; Qing Xia; Kang Ling; Xiaotong Wang; Xiumin Wang; Xunping Du
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

8.  Neural restrictive silencer factor and choline acetyltransferase expression in cerebral tissue of Alzheimer's Disease patients: A pilot study.

Authors:  Rocío E González-Castañeda; Víctor J Sánchez-González; Mario Flores-Soto; Gonzalo Vázquez-Camacho; Miguel A Macías-Islas; Genaro G Ortiz
Journal:  Genet Mol Biol       Date:  2013-03-04       Impact factor: 1.771

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.